Handelsbanken Fonder’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-23,000
Closed -$210K 1582
2023
Q1
$210K Hold
23,000
﹤0.01% 1435
2022
Q4
$262K Buy
+23,000
New +$341K ﹤0.01% 1318
2022
Q1
Sell
-11,200
Closed -$509K 1705
2021
Q4
$509K Hold
11,200
﹤0.01% 1332
2021
Q3
$710K Hold
11,200
﹤0.01% 1114
2021
Q2
$1.02M Buy
11,200
+2,200
+24% +$175K 0.01% 908
2021
Q1
$613K Sell
9,000
-1,100
-11% -$85.4K ﹤0.01% 1084
2020
Q4
$732K Buy
10,100
+2,800
+38% +$162K ﹤0.01% 963
2020
Q3
$277K Hold
7,300
﹤0.01% 1283
2020
Q2
$259K Buy
+7,300
New +$208K ﹤0.01% 1286

Other funds holding CDNA

Handelsbanken Fonder's CDNA Position: Q2 2023 in Review

Handelsbanken Fonder sold out of CareDx (CDNA) in Q2 2023, closing a stake of 23,000 shares — an estimated $210K sold.

Handelsbanken Fonder first reported a position in CDNA in Q2 2020 and held it in 9 quarters. The position peaked at $1.02M in Q2 2021. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2023.

  • Handelsbanken Fonder reported no remaining CareDx position as of Q2 2023 after selling out during the quarter.
  • Handelsbanken Fonder sold 23,000 CareDx shares in Q2 2023, an estimated $210K.
  • Handelsbanken Fonder first reported a position in CareDx in Q2 2020 and held it in 9 quarters.
  • Handelsbanken Fonder's CareDx position peaked at $1.02M in Q2 2021.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.